Sign in

CIK 0001665988

  • Accelerated filer
  • Emerging growth company

Bioventus Inc.

Sign in to watch
Ticker
BVS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
810980861
Phone
+1 919-474-6700
Business address
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
  1. 4 Open-market buy Director bought 65,022 shares at an average $4.64 ($301,688)
  2. 4 Open-market buy 10% owner bought 176,870 shares at an average $4.52 ($799,907)
  3. 4 Open-market buy Director bought 111,848 shares at $4.47 ($500,419)
  4. 4 Open-market sale SVP & Chief Compliance Officer sold 394 shares at $2.83 ($1,115)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Exercise or conversion Director acquired 1,813 shares (option exercise)
  10. 4 Exercise or conversion Director acquired 386 shares (option exercise)
  11. 4 Exercise or conversion Director acquired 965 shares (option exercise)
  12. 4 Open-market buy Director bought 292,126 shares at an average $3.38 ($987,185)
  13. 4 Open-market buy Director bought 455,725 shares at an average $2.94 ($1,338,164)
  14. 4 Exercise or conversion Director acquired 16,648 shares (option exercise)
  15. 4/A Open-market sale SVP & Chief Compliance Officer sold 131 shares at an average $7.69 ($1,007)
  16. 4 Exercise or conversion Director acquired 16,648 shares (option exercise)
  17. 4 Exercise or conversion Director acquired 16,648 shares (option exercise)
  18. 4 Exercise or conversion Director acquired 16,648 shares (option exercise)
  19. 4 Exercise or conversion Director acquired 16,648 shares (option exercise)
  20. 4 Exercise or conversion Director acquired 16,648 shares (option exercise)

Page 7 of 13 · 251 filings